Recent Progress in Developing Extracellular Vesicles as Nanovehicles to Deliver Carbohydrate-Based Therapeutics and Vaccines
Cell-derived, nanoscale extracellular vesicles (EVs) have emerged as promising tools in diagnostic, therapeutic, and vaccine applications. Their unique properties including the capability to encapsulate diverse molecular cargo as well as the versatility in surface functionalization make them ideal c...
Saved in:
| Main Authors: | Japigorn Puagsopa, Niksa Tongviseskul, Thapakorn Jaroentomeechai, Bunyarit Meksiriporn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/3/285 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracellular vesicles for delivering therapeutic agents in ischemia/reperfusion injury
by: Weihang Zhou, et al.
Published: (2024-12-01) -
MicroRNAs in circulating extracellular vesicles as biomarkers of early colorectal cancer captured using high mannose N-glycan-specific lectin from Oscillatoria Agardhii
by: Sanae Nakayama, et al.
Published: (2025-07-01) -
Guidance on the clinical application of extracellular vesicles
by: Shuji Terai, et al.
Published: (2025-06-01) -
Advances in the extracellular vesicles treatment of alopecia
by: Xiaoxin Wu, et al.
Published: (2025-12-01) -
Extracellular vesicles therapy: opportunities, mechanisms and perspectives
by: F. S. Velikonivtsev, et al.
Published: (2020-11-01)